Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Pedro González Santos"'
Autor:
Mariano Blasco, Ángel Díaz, Juan F. Ascaso, Xavier Pintó, Antonio Hernández-Mijares, Pedro González-Santos, Jesús Millán, Teresa Mantilla, Ángel Brea, Juan Pedro-Botet
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 29:185-200
Disease nonalcoholic fatty liver disease (NAFLD) comprises a series of histologically similar to those induced by alcohol consumption in people with very little or no liver damage same. The importance of NAFLD is its high prevalence in our Western so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a67817529c0e51ad8e709a836677a737
https://doi.org/10.1016/j.arteri.2016.06.002
https://doi.org/10.1016/j.arteri.2016.06.002
Autor:
Juan F. Ascaso, Ángel Díaz, Pedro González-Santos, Jesús Millán, Mariano Blasco, Teresa Mantilla, Antonio Hernández Mijares, Juan Pedro-Botet, Ángel Brea, Xavier Pintó
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 29:141-148
Non-alcoholic fatty liver disease (NAFLD) comprises a series of histologically lesions similar to those induced by alcohol consumption in people with very little or no liver damage. The importance of NAFLD is its high prevalence in the Western world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01730ca5f899b0a20670b28c787922db
https://doi.org/10.1016/j.arteri.2016.06.003
https://doi.org/10.1016/j.arteri.2016.06.003
Autor:
Pedro González-Santos, Antonio Hernández-Mijares, Juan Pedro-Botet, Teresa Mantilla, Jesús Millán, Mariano Blasco, Ángel Díaz, Juan F. Ascaso, Xavier Pintó, Ángel Brea
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 28:295-301
To control lipid factors risk, beyond proper management of LDL cholesterol according to individual risk, detection and treatment of atherogenic dyslipidemia and abnormal levels of triglycerides or HDL cholesterol it should be considered for address a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ec3e59308029e6aa9a237f988a47a05
https://doi.org/10.1016/j.arteri.2016.06.001
https://doi.org/10.1016/j.arteri.2016.06.001
Autor:
Antonio Hernández-Mijares, Ángel Díaz, Ángel Brea, Juan F. Ascaso, Jesús Millán, Xavier Pintó, Mariano Blasco, Pedro González-Santos, Teresa Mantilla, J. Pedro-Botet
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 28:265-270
Lowe density lipoproteins (LDL) are the causal agent of cardiovascular diseases. In practice, we identify LDL with cholesterol transported in LDL (cLDL). So, cLDL has become the major target for cardiovascular prevention. Howewer, we have progressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d98fa76bb5da055c9e9865ef37670fb6
https://doi.org/10.1016/j.arteri.2016.05.002
https://doi.org/10.1016/j.arteri.2016.05.002
Autor:
Pedro Gonzalez-Alegre, Marcelo L. Berthier, Ricardo E. Jorge, Alejandro Nabrozidis, Natalia García-Casares, Pedro González-Santos, José Rioja, María José Ariza, Antonio Gutiérrez, Laura Acion, Juan Garcia-Arnes
Publikováno v:
Journal of Alzheimer's Disease. 42:1337-1346
Background/Objective: The aim was to assess the neuropsychological performance of a group of middle-aged patients with well-controlled type 2 diabetes mellitus (T2DM) and to examine whether the neuropsychological deficits correlate with structural an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cd1e3fdad55cc05f402776b27aec664
https://doi.org/10.3233/jad-140702
https://doi.org/10.3233/jad-140702
Autor:
Pedro González Santos
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 26:7-11
With mixed dyslipidemia of the atherogenic dyslipidemia type, once the LDL-c objectives have been achieved through statin treatment, there is often a residual risk, for which the addition of a fibrate is recommended. The combination of statins and fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b5fdf91905ac79428a9a17aa4c4feb5
https://doi.org/10.1016/s0214-9168(14)70019-1
https://doi.org/10.1016/s0214-9168(14)70019-1
Autor:
Pedro González-Santos, Antonio Hernández-Mijares, Rafael Simó, Juan Pedro-Botet, Jesús Millán Núñez-Cortés, Ángel Brea-Hernando, Ángel Díaz-Rodríguez, Teresa Mantilla-Morató, Xavier Pintó-Sala
Publikováno v:
Revista Uruguaya de Cardiología, Volume: 29, Issue: 1, Pages: 97-98, Published: APR 2014
Resumen Introduccion y objetivos La dislipemia aterogenica es un reconocido factor de riesgo cardiovascular; sin embargo, en la practica clinica frecuentemente se subestima y, en consecuencia, esta infratratada e infracontrolada. El objetivo es desar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0656552f31f375ff613e564e0487decf
https://doi.org/10.1016/j.recesp.2013.06.014
https://doi.org/10.1016/j.recesp.2013.06.014
Autor:
Antonio Hernández-Mijares, Rafael Simó, Juan Pedro-Botet, Teresa Mantilla-Morató, Ángel Brea-Hernando, Ángel Díaz-Rodríguez, Xavier Pintó-Sala, Pedro González-Santos, Jesús Millán Núñez-Cortés
Publikováno v:
REVISTA ESPANOLA DE CARDIOLOGIA
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Revista espanola de cardiologia (English ed.)
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Revista espanola de cardiologia (English ed.)
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Introduction and objectives Although atherogenic dyslipidemia is a recognized cardiovascular risk factor, it is often underassessed and thus undertreated and poorly controlled in clinical practice. The objective of this study was to reach a multidisc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7005a4f4966d77dfcdc3f9250393e1cb
https://doi.org/10.1016/j.rec.2013.06.011
https://doi.org/10.1016/j.rec.2013.06.011
Autor:
Pedro González-Santos, Manuel de Haro Liger, Martina Álvarez Pérez, Antonio Fernández-Nebro, Manuel Abarca-Costalago, Ana Hidalgo-Conde, Pedro Valdivielso-Felices
Publikováno v:
Reumatología Clínica. 9:359-364
a b s t r a c t Objective: To determine the incidence and prevalence of cancer in a cohort of patients with systemic lupus erythematosus (SLE) and identify associated risk factors. Patients and methods: The study comprised a dynamic cohort of SLE pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce25b94608a41c37ac772ce4e1bcd2ec
https://doi.org/10.1016/j.reuma.2012.10.015
https://doi.org/10.1016/j.reuma.2012.10.015
Autor:
Mariano Blasco, Pedro González-Santos, Ángel Díaz, Teresa Mantilla, Juan F. Ascaso, Xavier Pintó, Jesús Millán, Antonio Hernández Mijares, Ángel Brea, Juan Pedro-Botet
Publikováno v:
Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis. 29(3)
Non-alcoholic fatty liver disease (NAFLD) comprises a series of histologically lesions similar to those induced by alcohol consumption in people with very little or no liver damage. The importance of NAFLD is its high prevalence in the Western world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704eebc34859b205df2c432cbdf115eb
https://pubmed.ncbi.nlm.nih.gov/27692633
https://pubmed.ncbi.nlm.nih.gov/27692633